Neuro-Oncology Reviews

Volume 28 Number 18
30 June 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 18, 30 June

Brizini M, Perreault S, Bennett J, Hassan H.
Advances in the management of pediatric low-grade glioma.
Neurotherapeutics. 2026 Jun 24;23(6):e00952. doi: 10.1016/j.neurot.2026.e00952. PMID: 42341366. ˍ

Kim KM, Byeon Y, Lee C, Lee WJ, Hwang K, Dho YS, Sung KS, Roh TH, Chong K, Park KS, Kang SH, Kim EH.
Targeting IDH-Mutant Glioma with Vorasidenib : A New Era in Precision Neuro-Oncology.
J Korean Neurosurg Soc. 2026 Jun 24. doi: 10.3340/jkns.2026.0113. PMID: 42342239. ˍ

Chan YB, Pang RKJ, Pang BC, Yeo TT, Tan BY.
Glioblastoma: current challenges and future horizons.
Singapore Med J. 2026 Jun 26;67(6):383-386. doi: 10.4103/singaporemedj.SMJ-2026-356. PMID: 42359712. ˍ

Lafont J, Kerhervé M, André N, Le Grand M, Pasquier E.
Precision neuro-oncology for children: Time to gear up!
Trends Cancer. 2026 Jun 26:S2405-8033(26)00129-9. doi: 10.1016/j.trecan.2026.06.001. PMID: 42350191. ˍ

Zhang D, Zhang Y, Liu F, Zhang C, Jiang S.
Radiotherapy resistance in glioblastoma: Mechanistic insights and novel therapeutic approaches (Review).
Int J Oncol. 2026 Jun 26;69(2):94. doi: 10.3892/ijo.2026.5907. PMID: 42359694. ˍ

Sabet K, Lovell H, Fonseca A.
Pediatric medulloblastoma.
Childs Nerv Syst. 2026 Jun 27;42(1):271. doi: 10.1007/s00381-026-07376-9. PMID: 42365163˰ ˍ

Lahariya R, Sinha M.
Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future.
Mol Biol Rep. 2026 Jun 30;53(1):1049. doi: 10.1007/s11033-026-12216-9. PMID: 42377714˰ ˍ

Leen D, Wong M, Lau E, Ng SP.
Differentiating glioma recurrence from radiation necrosis: a narrative review of positron emission tomography and magnetic resonance imaging and their diagnostic accuracies.
Chin Clin Oncol. 2026 Jun 30;15(3):44. doi: 10.21037/cco-24-133. PMID: 42425777. ˍ